VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CYHCommunity Health Systems, Inc.
$3.28$462M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCYHCash Flow

Community Health Systems, Inc. (CYH) Cash Flow Statement

27Y historyFree accessUpdated daily

Free cash flow generation is highly unstable, with margins ranging from -3.1% to 5.5% over the last ten quarters, necessitating a reliance on $1.1 billion in acquisition-related cash inflows in 2026Q1 to support liquidity.

CYH Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Cash from Operations126M543M480M210M300M-131M2.18B385M274M773M1.14B921M1.61B1.09B1.28B1.26B1.19B1.08B1.06B687.74M350.25M411.05M325.75M243.7M285.5M154.39M22.98M-11.75M
Operating CF Margin %-4.35%3.8%1.68%2.46%-1.06%18.47%2.91%1.94%5.03%6.17%4.74%8.66%8.38%9.83%10.6%10.43%8.89%9.75%9.65%8.02%11%9.77%8.6%12.97%9.12%1.72%-1.09%
Operating CF Growth %-334.24%13.13%128.57%-30%329.01%-106.01%465.71%40.51%-64.55%-32.01%23.45%-42.97%48.34%-14.95%1.44%6.16%10.43%1.81%53.73%96.35%-14.79%26.19%33.67%-14.64%84.92%571.69%295.68%-
Net Income-88M676M-516M-133M46M230M511M-675M-788M-2.45B-1.71B194M149M141.2M266.11M260.22M279.98M241.58M206.66M59.9M171.48M190.14M158.22M131.47M99.98M44.74M9.57M-16.79M
Depreciation & Amortization435M426M486M505M534M540M558M608M700M861M1.1B1.17B1.18B782.67M725.56M652.67M609.84M566.21M499.08M332.58M188.77M164.56M158.38M143.77M118.22M119.67M97.62M81.65M
Stock-Based Compensation3M11M00000000000000000000013K26K44K00
Deferred Taxes-235M-243M-116M35M165M170M-187M203M-3M-454M-116M103M107M69.28M53.41M107.03M97.37M34.27M159.87M-39.89M-25.23M9.89M41.9M61.57M38.17M25.28M17.21M-3.8M
Other Non-Cash Items-239M-330M635M193M34M305M-29M520M783M2.29B3.25B270M392M291.49M275.32M204.88M109.52M146.47M98.55M93.35M17.27M819K-106K2.31M7.7M3.81M-5.03M-570K
Working Capital Changes-335M3M-9M-390M-479M-1.38B1.32B-271M-418M525M-177M-818M-214M-195.93M-40.27M37.1M92.02M87.9M93.12M241.81M-2.04M45.64M-32.65M-95.43M21.4M-39.16M-96.46M-86.32M
Change in Receivables6M99M-66M-193M22M-136M309M93M31M732M-96M-219M-306M-285.44M-204.15M-138.33M-27.05M58.39M-57.44M131.3M-71.14M-47.45M-31.81M-150.84M-19.1M-22.94M00
Change in Inventory00000000000000000000-4.54M-16.84M-13.55M-13.73M-12.57M2M-15.6M-17.6M
Change in Payables-267M-36M137M-50M-158M16M-67M-157M0000147M72.47M246.3M246.11M161.95M86.1M119.6M125.96M52.15M84.96M-23.29M34.72M26M-26.95M00
Cash from Investing1.43B847M-277M-22M-251M-543M191M-3M-273M1.07B-608M-1.04B-4.35B-991.27M-1.38B-1.2B-1.04B-867.18M-665.47M-7.5B-640.26M-327.27M-318.48M-620.77M-291.14M-265.11M-244.44M-155.54M
Capital Expenditures-326M-335M-360M-467M-415M-469M-440M-438M-527M-570M-867M-1.01B-853M-613.99M-768.79M-1.19B-667.38M-576.89M-692.23M-522.78M-260.87M-223.22M-194.09M-596.95M-103.97M-83.23M-63.01M-80.25M
CapEx % of Revenue1.52%2.68%2.85%3.74%3.4%3.79%3.73%3.32%3.72%3.71%4.7%5.2%4.58%4.72%5.9%10.01%5.86%4.76%6.39%7.33%5.98%5.97%5.82%21.06%4.73%4.91%4.71%7.43%
Acquisitions1.8B1.26B152M426M126M5M665M593M359M1.7B139M181M-2.95B-37.33M-316.42M184.55M-239.85M-170.24M217.21M-6.9B-379.39M-104.06M-124.39M00-150.94M-148.22M-59.7M
Investments----------------------------
Other Investing-7M-62M00121M00000000-339.94M00-137.08M-120.05M-190.45M-72.67M000-23.82M-187.16M-30.94M-33.22M-15.59M
Cash from Financing-1.27B-1.17B-204M-268M-438M-495M-909M-362M-368M-1.52B-1.69B-206M2.87B-111.86M361.03M-235.44M-189.79M-85.36M-304.03M6.9B226.46M-62.17M58.9M260.55M130.1M105.37M230.91M164.85M
Debt Issued (Net)-1.08B-1B-48M-123M-305M-369M-794M-322M-1.07B-1.52B-1.86B-158M2.88B-440.61M130.14M-92.65M-61.48M-58.26M-106.78M6.9B380.78M-26.84M357.06M275.16M137.34M-197.89M-284.25M165.41M
Equity Issued (Net)-2M-2M-1M-4M-8M-5M-1M-1M-1M-5M-6M-154M45M68.63M11.54M-66.88M-57.05M12.76M-88.38M8.21M-161.74M-31.53M-280.62M-10.44M2.54M308.97M515.16M-565K
Dividends Paid00000000000000-22.54M0000000-1.24M00000
Share Repurchases-2M-2M-1M-4M-8M-5M-1M-1M-1M-5M-6M-179M-20M-42.03M-9.31M-85.79M-113.96M0-90.19M0-176.32M-79.85M-290.52M-14.71M0-91K0-2.78M
Other Financing-186M-165M-155M-141M-125M-121M-114M-39M701M5M174M106M-48M260.12M241.88M-75.91M-71.27M-39.87M-108.87M-4.43M7.42M-3.8M-17.54M-4.16M-9.79M-5.71M00
Net Change in Cash281M223M-1M-80M-389M-1.17B1.46B20M-367M325M54M-325M136M-14.41M257.95M-169.3M-45.37M123.89M87.78M92.31M-63.54M21.61M66.17M-116.51M124.46M-5.35M9.46M-2.44M
Free Cash Flow-200M208M120M-257M-115M-600M1.74B-53M-253M203M1.49B-89M762M474.73M511.33M69.83M521.35M499.54M365.05M164.95M125.74M222.68M161.46M-353.25M181.52M71.16M-40.02M-92M
FCF Margin %-0.93%1.67%0.95%-2.06%-0.94%-4.85%14.74%-0.4%-1.79%1.32%8.08%-0.46%4.09%3.65%3.92%0.59%4.57%4.13%3.37%2.31%2.88%5.96%4.84%-12.46%8.25%4.2%-2.99%-8.52%
FCF Growth %-231.58%73.33%146.69%-123.48%80.83%-134.52%3379.25%79.05%-224.63%-86.37%1773.03%-111.68%60.51%-7.16%632.2%-86.61%4.37%36.84%121.3%31.19%-43.54%37.92%145.71%-294.6%155.11%277.8%56.5%-
FCF per Share-1.481.540.91-1.97-0.88-4.5914.91-0.47-2.241.8213.45-0.776.745.065.690.775.615.463.871.741.312.261.61-3.491.670.79-0.58-1.69
FCF Conversion (FCF/Net Income)2.27x1.07x-0.93x-1.58x6.52x-0.57x4.26x-0.65x-0.35x-0.31x-0.66x5.83x17.55x7.71x4.82x6.25x4.25x4.43x4.84x22.71x2.08x2.45x2.15x1.85x2.86x3.45x2.40x0.70x
Interest Paid215M000000000000000000000000000
Taxes Paid91M000000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

High leverage and refinancing

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Disconnected from Cash

As reported in recent financial filings, the relationship between net income and operating cash flow remains highly erratic, with the OCF/NI ratio swinging from -9.23 in 2025Q1 to 2.42 in 2025Q4, indicating that accounting accruals and non-cash charges frequently obscure the company's actual cash-generating capacity.

The persistent divergence between bottom-line results and cash flow suggests that reported net income is heavily influenced by non-recurring items and significant impairment charges. Investors should interpret these fluctuations as a sign that core operational cash flow is not reliably tracking with accounting profitability, complicating any assessment of true earnings quality.

Free Cash Flow Volatility Persists

Based on the provided quarterly data, CYH's free cash flow trajectory is characterized by extreme instability, with margins fluctuating between -3.1% and 5.5% over the last ten quarters, reflecting a business model that struggles to maintain consistent cash generation amidst ongoing portfolio rationalization and operational headwinds.

The inability to sustain positive free cash flow suggests that the company's capital requirements often outpace its operational inflows. This inconsistency warrants further investigation into whether the current divestiture strategy is successfully reducing the cash-burn profile or merely masking underlying structural inefficiencies in the remaining hospital network.

Working Capital Swings Impair Liquidity

According to recent SEC filings, working capital changes have been a significant source of volatility for CYH, with a notable $347 million outflow in 2026Q1, suggesting that the company faces recurring challenges in managing its cash conversion cycle and timing of payments relative to patient service collections.

These sharp swings in working capital indicate potential friction in the revenue cycle, possibly tied to the timing of government reimbursements or shifts in payer mix. Such volatility in liquidity management may force the company to rely more heavily on external financing to bridge gaps during periods of negative working capital movement.

Divestitures Funding Debt Reduction Efforts

As reported in financial statements, CYH has utilized significant proceeds from asset sales, including $1.1 billion in 2026Q1, to manage its capital structure, highlighting a reliance on divestitures to offset operational cash shortfalls and address the company's substantial debt obligations in a high-interest rate environment.

The reliance on net acquisition proceeds to bolster cash flow suggests that the company is effectively liquidating its asset base to maintain solvency. While this provides immediate liquidity, it appears to be a defensive measure that limits future growth potential and leaves the company with a smaller, potentially less efficient operational footprint.

CYH — Frequently Asked Questions

Quick answers to the most common questions about buying CYH stock.

How much cash does Community Health Systems, Inc. (CYH) generate from operations?

Community Health Systems, Inc. (CYH) generated $543.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Community Health Systems, Inc.'s free cash flow?

Community Health Systems, Inc. (CYH) generated $208.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Community Health Systems, Inc.'s capital expenditure (CapEx)?

Community Health Systems, Inc. (CYH) spent $335.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Community Health Systems, Inc. distribute cash to shareholders?

In 2025, Community Health Systems, Inc. (CYH) spent $2.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.